These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Liposomes with conjugates of a calix[4]arene and a Gd-DOTA derivative on the outside surface; an efficient potential contrast agent for MRI. Schühle DT; van Rijn P; Laurent S; Vander Elst L; Muller RN; Stuart MC; Schatz J; Peters JA Chem Commun (Camb); 2010 Jun; 46(24):4399-401. PubMed ID: 20467663 [TBL] [Abstract][Full Text] [Related]
4. Paramagnetic liposomes as MRI contrast agents: influence of liposomal physicochemical properties on the in vitro relaxivity. Fossheim SL; Fahlvik AK; Klaveness J; Muller RN Magn Reson Imaging; 1999 Jan; 17(1):83-9. PubMed ID: 9888401 [TBL] [Abstract][Full Text] [Related]
5. Insights on the relaxation of liposomes encapsulating paramagnetic Ln-based complexes. Mulas G; Ferrauto G; Dastrù W; Anedda R; Aime S; Terreno E Magn Reson Med; 2015 Aug; 74(2):468-73. PubMed ID: 25186276 [TBL] [Abstract][Full Text] [Related]
6. Physical, chemical and biological evaluations of CMD-A2-Gd-DOTA. A new paramagnetic dextran polymer. Corot C; Schaefer M; Beauté S; Bourrinet P; Zehaf S; Bénizé V; Sabatou M; Meyer D Acta Radiol Suppl; 1997; 412():91-9. PubMed ID: 9240087 [TBL] [Abstract][Full Text] [Related]
7. Cyclen-based Gd Rashid HU; Martines MAU; Jorge J; de Moraes PM; Umar MN; Khan K; Rehman HU Bioorg Med Chem; 2016 Nov; 24(22):5663-5684. PubMed ID: 27729196 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and relaxivity studies of a tetranuclear gadolinium(III) complex of DO3A as a contrast-enhancing agent for MRI. Jebasingh B; Alexander V Inorg Chem; 2005 Dec; 44(25):9434-43. PubMed ID: 16323930 [TBL] [Abstract][Full Text] [Related]
9. Hydrogels incorporating GdDOTA: towards highly efficient dual T1/T2 MRI contrast agents. Courant T; Roullin VG; Cadiou C; Callewaert M; Andry MC; Portefaix C; Hoeffel C; de Goltstein MC; Port M; Laurent S; Elst LV; Muller R; Molinari M; Chuburu F Angew Chem Int Ed Engl; 2012 Sep; 51(36):9119-22. PubMed ID: 22865621 [TBL] [Abstract][Full Text] [Related]
10. A multiple gadolinium complex decorated fullerene as a highly sensitive T(1) contrast agent. Wang L; Zhu X; Tang X; Wu C; Zhou Z; Sun C; Deng SL; Ai H; Gao J Chem Commun (Camb); 2015 Mar; 51(21):4390-3. PubMed ID: 25676633 [TBL] [Abstract][Full Text] [Related]
11. Gadolinium-doped LipoCEST agents: a potential novel class of dual 1H-MRI probes. Terreno E; Boffa C; Menchise V; Fedeli F; Carrera C; Castelli DD; Digilio G; Aime S Chem Commun (Camb); 2011 Apr; 47(16):4667-9. PubMed ID: 21409237 [TBL] [Abstract][Full Text] [Related]
12. T1 relaxivity of core-encapsulated gadolinium liposomal contrast agents--effect of liposome size and internal gadolinium concentration. Ghaghada K; Hawley C; Kawaji K; Annapragada A; Mukundan S Acad Radiol; 2008 Oct; 15(10):1259-63. PubMed ID: 18790397 [TBL] [Abstract][Full Text] [Related]
13. Paramagnetic liposomes as magnetic resonance imaging contrast agents. Assessment of contrast efficacy in various liver models. Fossheim SL; Colet JM; Månsson S; Fahlvik AK; Muller RN; Klaveness J Invest Radiol; 1998 Nov; 33(11):810-21. PubMed ID: 9818315 [TBL] [Abstract][Full Text] [Related]
14. High-relaxivity magnetic resonance imaging (MRI) contrast agent based on supramolecular assembly between a gadolinium chelate, a modified dextran, and poly-beta-cyclodextrin. Battistini E; Gianolio E; Gref R; Couvreur P; Fuzerova S; Othman M; Aime S; Badet B; Durand P Chemistry; 2008; 14(15):4551-61. PubMed ID: 18386282 [TBL] [Abstract][Full Text] [Related]
15. Paramagnetic liposomes containing amphiphilic bisamide derivatives of Gd-DTPA with aromatic side chain groups as possible contrast agents for magnetic resonance imaging. Parac-Vogt TN; Kimpe K; Laurent S; Piérart C; Elst LV; Muller RN; Binnemans K Eur Biophys J; 2006 Jan; 35(2):136-44. PubMed ID: 16217648 [TBL] [Abstract][Full Text] [Related]
16. Gd(DOTA)-grafted submicronic polysaccharide-based particles functionalized with fucoidan as potential MR contrast agent able to target human activated platelets. Forero Ramirez LM; Gobin E; Aid-Launais R; Journe C; Moraes FC; Picton L; Le Cerf D; Letourneur D; Chauvierre C; Chaubet F Carbohydr Polym; 2020 Oct; 245():116457. PubMed ID: 32718599 [TBL] [Abstract][Full Text] [Related]
18. Gadolinium chelate with DO3A conjugated 2-(diphenylphosphoryl)-ethyldiphenylphosphonium cation as potential tumor-selective MRI contrast agent. Chandrasekharan P; Yong CX; Poh Z; He T; He Z; Liu S; Robins EG; Chuang KH; Yang CT Biomaterials; 2012 Dec; 33(36):9225-31. PubMed ID: 23026708 [TBL] [Abstract][Full Text] [Related]
19. Relaxivity of Gd-Based MRI Contrast Agents in Crosslinked Hyaluronic Acid as a Model for Tissues. Fragai M; Ravera E; Tedoldi F; Luchinat C; Parigi G Chemphyschem; 2019 Sep; 20(17):2204-2209. PubMed ID: 31298452 [TBL] [Abstract][Full Text] [Related]